Evidence mapPaperPMID 36920206Full record

ArticleAntimicrobial agents and chemotherapy2023

Pharmacological Elevation of Cellular Dihydrosphingomyelin Provides a Novel Antiviral Strategy against West Nile Virus Infection.

Nereida Jiménez de Oya, Ana San-Félix, Mireia Casasampere, Ana-Belén Blázquez, Patricia Mingo-Casas, Estela Escribano-Romero, Eva Calvo-Pinilla, Teresa Poderoso, Josefina Casas, Juan-Carlos Saiz and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. ThemBio · 2024
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Nereida Jiménez de OyaZOOVIR, Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.ORCID 0000-0003-3129-813X
Ana San-FélixInstituto de Quimica Medica (IQM), CSIC, Madrid, Spain.
Mireia CasasampereDepartment of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC), CSIC, Barcelona, Spain.
Ana-Belén BlázquezZOOVIR, Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.ORCID 0000-0002-0847-0977
Patricia Mingo-CasasZOOVIR, Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Estela Escribano-RomeroZOOVIR, Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.ORCID 0000-0002-5036-7607
Eva Calvo-PinillaZOOVIR, Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Teresa PoderosoZOOVIR, Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Josefina CasasDepartment of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC), CSIC, Barcelona, Spain.
Juan-Carlos SaizZOOVIR, Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
María-Jesús Pérez-PérezInstituto de Quimica Medica (IQM), CSIC, Madrid, Spain.
Miguel A Martín-AcebesZOOVIR, Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.ORCID 0000-0001-6015-3613
Consejo Superior de Investigaciones Científicas · ESInstituto de Química Médica · ESInstitute of Advanced Chemistry of Catalonia · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The flavivirus life cycle is strictly dependent on cellular lipid metabolism. Polyphenols like gallic acid and its derivatives are promising lead compounds for new therapeutic agents as they can exert multiple pharmacological activities, including the alteration of lipid metabolism. The evaluation of our collection of polyphenols against West Nile virus (WNV), a representative medically relevant flavivirus, led to the identification of

Indexed as

FlavivirusNeuroblastomaWest Nile FeverWest Nile virusZika VirusZika Virus InfectionAnimalsAntiviral AgentsChlorocebus aethiopsHumansVero CellsVirus ReplicationAntiviral Agentsantiviralantiviral agentsflaviviruspolyphenolpolyphenolssphingolipidWest Nile virus

Identifiers

PMID36920206
PMCPMC10112131
OpenAlexW4324311306

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.